SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001703057-23-000047
Filing Date
2023-11-28
Accepted
2023-11-28 17:28:36
Documents
12
Period of Report
2023-11-28
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20231128.htm   iXBRL 8-K 23870
  Complete submission text file 0001703057-23-000047.txt   143957

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20231128.xsd EX-101.SCH 1907
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20231128_lab.xml EX-101.LAB 22785
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20231128_pre.xml EX-101.PRE 11962
6 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20231128_htm.xml XML 2593
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 231447676
SIC: 2834 Pharmaceutical Preparations